117 related articles for article (PubMed ID: 6168716)
1. Interferons as antitumor agents.
Taylor S
J Kans Med Soc; 1981 Mar; 82(3):128-30, 138. PubMed ID: 6168716
[No Abstract] [Full Text] [Related]
2. Interferon treatment of human neoplasia.
Strander H
Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
[No Abstract] [Full Text] [Related]
3. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
4. Interferon therapy in cancer: from imaginon to interferon.
Goldstein D; Laszlo J
Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950
[No Abstract] [Full Text] [Related]
5. Interferons: in pursuit of the promise.
Borden EC
Prog Clin Biol Res; 1983; 132E():287-96. PubMed ID: 6196788
[No Abstract] [Full Text] [Related]
6. Interferon: anticancer agent having multifarious activity.
Yabrov AA
Prog Clin Cancer; 1982; 8():99-145. PubMed ID: 6185970
[No Abstract] [Full Text] [Related]
7. Interferons in the treatment of human cancer.
Kirkwood JM; Ernstoff MS
J Clin Oncol; 1984 Apr; 2(4):336-52. PubMed ID: 6323641
[TBL] [Abstract][Full Text] [Related]
8. Studies on antiviral and antitumor effects of human leukocyte interferon in vitro and in vivo.
Strander H; Cantell K
In Vitro Monogr; 1974; (3):49-56. PubMed ID: 4471024
[No Abstract] [Full Text] [Related]
9. [Interferon in antitumoral chemotherapy].
Soria M
Recenti Prog Med; 1981 May; 70(5):494-523. PubMed ID: 6171850
[No Abstract] [Full Text] [Related]
10. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
Wagstaff J; Scarffe JH; Crowther D
Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
[No Abstract] [Full Text] [Related]
11. [Interferons: Clinical applications in hematology].
Ben Rhomdhane N; Ben Ahmed M; Zitouni M; Mtimet B
Tunis Med; 1998 Dec; 76(12):427-36. PubMed ID: 10093482
[No Abstract] [Full Text] [Related]
12. Interferons in oncology.
Woll PJ; Pettengell R
Br J Clin Pract; 1997 Mar; 51(2):111-5. PubMed ID: 9158255
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow and peripheral blood stem cell transplantation for malignancy.
Johnson PW; Simnett SJ; Sweetenham JW; Morgan GJ; Stewart LA
Health Technol Assess; 1998; 2(8):1-187. PubMed ID: 9728295
[No Abstract] [Full Text] [Related]
14. Present status and future problems of interferon in the treatment of hematological malignancies.
Kimura K
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1677-87. PubMed ID: 2425532
[No Abstract] [Full Text] [Related]
15. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.
Gutterman JU; Blumenschein GR; Alexanian R; Yap HY; Buzdar AU; Cabanillas F; Hortobagyi GN; Hersh EM; Rasmussen SL; Harmon M; Kramer M; Pestka S
Ann Intern Med; 1980 Sep; 93(3):399-406. PubMed ID: 6159812
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and immunological studies of human fibroblast interferon and human lymphoblastoid interferon in malignant diseases].
Ezaki K
Gan No Rinsho; 1983 May; 29(6):598-602. PubMed ID: 6308306
[No Abstract] [Full Text] [Related]
17. Systemic therapy for breast cancer: changing trends, 1980.
Vogel CL
Compr Ther; 1980 Oct; 6(10):48-53. PubMed ID: 7449365
[No Abstract] [Full Text] [Related]
18. [Interferon (IFN) in multiple myeloma and non-Hodgkin's lymphoma].
Gola A
Acta Haematol Pol; 1994; 25(2 Suppl 1):136-41. PubMed ID: 7520658
[TBL] [Abstract][Full Text] [Related]
19. Interferons in the treatment of advanced breast cancer.
Repetto L; Venturino A; Simoni C; Rosso M; Melioli G; Rosso R
J Biol Regul Homeost Agents; 1993; 7(4):109-14. PubMed ID: 7517612
[TBL] [Abstract][Full Text] [Related]
20. [Effects of interferon on various malignancies].
Taguchi T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]